Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Electrochemically Deposited Calcium Phosphate Coatings Using a Potentiostat of In-house Design and Implementation

Autor: F. N. Jiménez-García, L.R. Giraldo-Torres, E. Restrepo-Parra

Publikováno v: Materials Research, Vol 24, Iss 5 (2021)

Abstract The effect of growth conditions and post treatments on the properties of calcium phosphate films electrodeposited by a potentiostat of the authors’ design and construction is presented. The electrolyte used was formed with 0.025 M (NH4)H2P

Externí odkaz: https://doaj.org/article/af21aea90c2147e5b807d8e440a1571a

Valorization of human hair as methylene blue dye adsorbents

Autor: Ahmad Zaini Muhammad Abbas, Sudi Raidah Md.

Publikováno v: Green Processing and Synthesis, Vol 7, Iss 4, Pp 344-352 (2018)

The present study was aimed at evaluating the performance of human hair as adsorbents for methylene blue (MB) dye removal. Human hair was treated using 0.1 m potassium hydroxide (KOH) and 0.1 m nitric acid, and the adsorbents were characterized for s

Externí odkaz: https://doaj.org/article/61aa2f9436ce4c6f9b89ed60b489d472

EFFICACY OF MELDONIUM IN ACUTE PERIOD OF ISCHEMIC STROKE

Autor: S. V. Kotov, E. V. Isakova, T. V. Volchenkova, L. V. Smetana, S. N. Belkina

Publikováno v: Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 39, Pp 75-81 (2016)

Background: As long as systemic thrombolysis is indicated to not more than 10% of patients with ischemic stroke, the search for medical agents for basic treatment of stroke is an important problem of today’s neurology.Aim: To evaluate efficacy of m

Externí odkaz: https://doaj.org/article/6703dc03232f42538cab5e31c97b758b

The evaluation of approaches to the treatment of myasthenia gravis

Autor: N. P. Shastun, O. I. Kalbus, Yu. V. Bukreyeva, S. O. Makarov, O. V. Somilo

Publikováno v: Medičnì Perspektivi, Vol 24, Iss 3, Pp 80-86 (2019)
Medicni perspektivi (Medical perspectives); Том 24, № 3 (2019); 80-86
Медичні перспективи; Том 24, № 3 (2019); 80-86

Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5f2fb89c1ceec17e3d3e8affc0b0fc
http://journals.uran.ua/index.php/2307-0404/article/view/181886